Candoo Pharmatech Company Inc.
Jason Liu has extensive work experience in various roles within the pharmaceutical, scientific, and engineering fields. Jason started their career at BASF as a Summer Intern in 2011 before moving on to work as a Research Intern at the Institute of Process Engineering, Chinese Academy of Sciences. In 2012, Jason joined Western University as a Master of Chemical & Biochemical Engineering student, where they also served as a Teaching Assistant. During their time at Western University, Jason independently designed and set up a 10-meter-tall liquid-solid fluidized-bed reactor. Jason also completed their Ph.D. in Chemical & Biochemical Engineering, focusing on performance optimization and troubleshooting equipment malfunctions. After completing their Ph.D., Jason obtained a position at Mondelēz International as a Quality Engineer, where they championed Lean/6-Sigma activities and participated in continuous improvement projects. Jason then joined Thermo Fisher Scientific as a Scientist before transitioning to their most recent role as a Process Scientist at Candoo Pharmatech Company Inc. Here, they led product and manufacturing process development projects, troubleshooting technical issues, creating work orders, and preparing certification applications for FDA. Jason is experienced in equipment commissioning, coordinating with contractors and auditors, and managing development projects.
Jason Liu holds a Doctor of Philosophy (Ph.D.) degree in Fluidization, Particle technology, Multiphase flow, and Reactor engineering from Western University, which they obtained from 2013 to 2016. Prior to that, they received a Master's Degree in Emulsification, Colloidal system, and Membrane technology from the same institution in 2012 and 2013. Jason also holds a Bachelor's Degree in Chemical Engineering from Beijing University of Chemical Technology, which they achieved between 2008 and 2012. In addition, they have obtained certifications in Lean Six Sigma Green Belt from the Management and Strategy Institute and Workplace Hazardous Materials Information System from Western University.
This person is not in any teams
Candoo Pharmatech Company Inc.
Candoo Pharmatech Company Inc. is a technology-driven, customer-centric pharmaceutical CDMO specializing in advanced formulation and manufacturing solutions to small and large molecules. Candoo believes an innovative, efficient and affordable drug delivery platform is pivotal to substantially reduce the cost of new drug access. We provide experienced, agile and cost-effective contract development and manufacturing services including pre-formulation, formulation, analytical, dissolution, manufacturing, regulatory submission, GastroPlus modeling and IVIVC, and toxicology evaluation for global pharmaceutical and biotech industries. We have proven track record of success to develop first-to-file products (Paragraph IV), achieve target drug absorption profile, pass bioequivalence studies right-first-time, and get FDA regulatory approval within one review cycle. Our expertise spans a broad spectrum of oral, topical and parenteral dosage forms in the fields of NDA, 505b(2) and generics (ANDA). We effectively support pharma, biotech and medical research institutions all over the world accelerate molecules to medicines with PBPK model-informed developability assessment, best fit formulation, scalable manufacturing process and faster turnaround time. Candoo was founded in 2018 and is a Canadian subsidiary of Crystal Pharmatech. As a member of Ontario Research Innovation & Commercialization Center, industrial partner of Canada Natural Sciences and Engineering Research Council (NSERC) CREATE Training Program for Controlled Release Leaders (ContRoL) and Mitacs Research and Development Program, Candoo has the state-of-the-art R&D and cGMP facilities of 12,500 square feet (cGMP facility under renovation), equipped with modern and cGMP-compliance equipment, and locates at the pharmaceutical business park in Mississauga, Ontario, the hub of pharmaceutical industry in Canada.